What is LINEA System?
LINEA System specializes in accelerating clinical trials through its innovative Study Start-up Management System (SSMS), Acceletrl. The platform leverages advanced technology and data to streamline the study start-up process for sponsors and clinical research organizations (CROs). By providing efficient site identification and engagement solutions, and boasting a vast network of over 300,000 global investigators, LINEA System offers customized plans to ensure optimal site selection and patient enrollment. Their client base includes leading pharmaceutical companies and biotech firms, all of whom benefit from LINEA's commitment to excellence and world-class customer service.
How much funding has LINEA System raised?
LINEA System has raised a total of $64K across 1 funding round:
Debt
$64K
Debt (2021): $64K with participation from PPP
Key Investors in LINEA System
PPP
Public-Private Partnership
What's next for LINEA System?
With significant backing at a Series B/C stage, LINEA System is poised for strategic expansion. The recent influx of capital is expected to fuel further technological advancements in their Acceletrl platform, enhance their investigator network outreach, and potentially broaden their market penetration into new geographical regions. This investment signals strong confidence from stakeholders in LINEA System's ability to further optimize and expedite the critical study start-up phase for clinical research, a key bottleneck in drug development.
See full LINEA System company page
